Description
This newsletter explains why the 2013 obesity guideline was retired and replaced by the 2026 CKM Guideline’s reframing of adiposity as a modifiable driver of cardiovascular, kidney, and metabolic disease. It summarises the conceptual shift from treating weight as an isolated number to assessing abdominal adiposity (waist circumference) alongside BMI, highlights epidemiologic and outcome data linking excess weight to heart, kidney, and stroke risk, and outlines the guideline’s practical recommendations: integrate waist measurement into risk assessment, prioritise lifestyle intervention plus evidence‑based obesity pharmacotherapy, consider metabolic/bariatric surgery when indicated, and use patient‑centred, non‑stigmatizing communication.